SCHEMBL22149135

SCHEMBL22149135

CCCCn1c2ccccc2c2c3cc(OC)c(OC)cc3c3c(c21)C=CC(c1ccccc1)(c1ccc(OC)cc1)O3

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SLC6A1 P30531 1/20 0.35
SLC6A12 P48065 1/20 0.35
SLC6A11 P48066 1/20 0.35
MYLK Q15746 1/20 0.35
DYRK1A Q13627 1/20 0.35
PDE5A O76074 1/20 0.34
CNR2 P34972 3/20 0.34
PIM3 Q86V86 1/20 0.34
PSEN1 P49768 5/20 0.34
PSEN2 P49810 5/20 0.34
APH1B Q8WW43 5/20 0.34
NCSTN Q92542 5/20 0.34
APH1A Q96BI3 5/20 0.34
PSENEN Q9NZ42 5/20 0.34
ALPL P05186 1/20 0.34
ALPG P10696 1/20 0.34
KCNA3 P22001 1/20 0.34
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22149102 0.85 PIM3 (0.41) MEN1KMT2ACNR2PIM3ALPL
SCHEMBL22148960 0.85 PGR (0.34) MEN1KMT2ADYRK1A
SCHEMBL23919144 0.83 KDM4E (0.35) MEN1KMT2AKDM4EHSD17B10
SCHEMBL23919130 0.82 MAPT (0.36) MEN1KMT2AKDM4EHSD17B10
SCHEMBL22148997 0.78 PGR (0.38) DYRK1ACNR2PIM3CNR1
SCHEMBL22145128 0.76 KDM4E (0.38) MEN1KMT2AMYLKKDM4EHSD17B10
SCHEMBL22145250 0.76 KDM4E (0.36) MEN1KMT2AKDM4EHSD17B10NPC1
SCHEMBL22145217 0.75 MAT2A (0.39)
SCHEMBL22145205 0.74 EDNRA (0.34) MEN1KMT2AKDM4EHSD17B10
SCHEMBL22145135 0.74 EDNRA (0.36) MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317129-A1 Indolenaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2021-10-14 US disclosed
WO-2020126029-A1 ARTICLES COMPRISING INDOLENAPHTHOPYRANS TRANSITIONS OPTICAL, LTD. (IE) 2020-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317129-A1 Indolenaphthopyrans AHR, TDO2, TPH2 MEN1 3107/4885KMT2A 2760/4885SLC6A1 2347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.